The sexual desire inventory: Development, factor structure, and evidence of reliability

Spector, Ilana P.; Carey, Michael P.; Steinberg, Lynne

doi:10.1080/00926239608414655

Cited by 534 publications

(434 citation statements)

References 17 publications

Supporting

Mentioning

399

Contrasting

Unclassified

Order By: Relevance

“…In the present study, 14 days supplementation of ME significantly increased self rated sexual desire [12] with no changes being observed in the placebo trial. These findings support previous in vivo investigations into the effect of maca consumption on sexual desire in humans and rats [2,4].…”

Section: Discussioncontrasting

confidence: 58%

“…In this study, participants were subjectively asked to simply report if treatment diminished, did not change, increased mildly or increased moderately to highly sexual desire. In the present study 14 days proved sufficient to elucidate a response in sexual desire, which was analysed using a dichotomous sexual desire inventory with consisting 14 questions targeting both dyadic and solitary sexual desire [12]. This method is less subjective and thus may be more responsive to change.…”

Section: Discussionmentioning

confidence: 90%

“…The SDI is a self administered 14 item questionnaire designed to measure 2 aspects of sexual desire; specifically dyadic (questions 1-9; see Figure 2 ) and solitary desire (questions 10-13; see Figure 2). A high degree of reliability for both subscales (α = 0.86 for dyadic desire; α = 0.96 for solitary sexual desire) has been reported by its authors [12]. All items are rated using a Likert-type scale and are summed to calculate an SDI total score.…”

Section: Testing Proceduresmentioning

confidence: 95%

“…Immediately before each time trial, subjects completed the Sexual Desire Inventory (SDI) [12] and returned the forms in a sealed envelope to the investigator. The SDI is a self administered 14 item questionnaire designed to measure 2 aspects of sexual desire; specifically dyadic (questions 1-9; see Figure 2 ) and solitary desire (questions 10-13; see Figure 2).…”

Section: Testing Proceduresmentioning

confidence: 99%

See 3 more Smart Citations

A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen

Stone

Ibarra

Roller

et al. 2009

Journal of Ethnopharmacology

View full text Add to dashboard Cite

A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. Journal of Ethnopharmacology, 126 (3 Northumbria University has developed Northumbria Research Link (NRL) to enable users to access the University's research output. Copyright © and moral rights for items on NRL are retained by the individual author(s) and/or other copyright owners. Single copies of full items can be reproduced, displayed or performed, and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata page. The content must not be changed in any way. Full items must not be sold commercially in any format or medium without formal permission of the copyright holder. The full policy is available online: http://nrl.northumbria.ac.uk/policies.html This document may differ from the final, published version of the research and has been made available online in accordance with publisher policies. To read and/or cite from the published version of the research, please visit the publisher's website (a subscription may be required.) trial before and after 14 days supplementation with both maca extract (ME) and placebo, in a randomised crossover design. Subjects also completed a sexual desire inventory during each visit. Results: ME administration significantly improved 40 km cycling time performance compared to the baseline test (P = 0.01), but not compared to the placebo trial after supplementation (P >0.05). ME administration significantly improved the self rated sexual desire score compared to the baseline test (P = 0.01), and compared to the placebo trial after supplementation (P = 0.03). Conclusion: 14 days ME supplementation improved 40km cycling time trial performance and sexual desire in trained male cyclists. These promising results encourage long-term clinical studies involving more volunteers, to further evaluate the efficacy of ME in athletes and normal individuals and also to explore its possible mechanisms of action.

show abstract

Section: Discussioncontrasting

confidence: 58%

Section: Discussionmentioning

confidence: 90%

Section: Testing Proceduresmentioning

confidence: 95%

Section: Testing Proceduresmentioning

confidence: 99%

See 2 more Smart Citations

A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen

Stone

Ibarra

Roller

et al. 2009

Journal of Ethnopharmacology

View full text Add to dashboard Cite

show abstract

“…In a study, they conducted relying on the assumption that migraines and sex drive could be modified by similar serotonergic systems, Houle et al 18 found that those who suffered from migraines reported a higher sex drive than those suffering from tension-type headaches. In our study, we did not use a specific scale to evaluate sex drive, such as the Sexual Desire Inventory, 19 whereas Houle et al 18 did; and this might account for our failure to detect any such difference. In further studies, it would be advantageous to assess sex drive in different subgroups of headache patient using a more detailed survey instrument.…”

Section: Discussionmentioning

confidence: 80%

Sexual dysfunction in women with migraine versus tension-type headaches: a comparative study

et al. 2011

View full text Add to dashboard Cite

The aim of this study was to compare the incidence of sexual dysfunction between patients with tension-type headaches (T), migraines (M) and healthy controls (C) in order to investigate the relationship between sexual dysfunction and the features of headaches. The population comprised of 44 patients with M, 30 with T and 30 with C. They have completed Arizona Sexual Experiences Scale (ASEX), Visual Analog Scale. The number of sexual activities over the past 30 days and the frequency of masturbation behavior in C were considerably higher than those in the headache groups. The averages for ASEX item no. 1, 2, 3 and 4 were significantly higher in those with M versus C; and both the subscales and total scores of ASEX were also higher in those with T than C. The mean score for ASEX item no. 3 and the total ASEX score were significantly higher in T versus M. In both headache groups, no significant relationship was observed between headache features and ASEX. The present study showed that patients with either M or T do experience problems in several aspects of sexuality compared with C. Further research is essential to augment our understanding of the sexual dysfunction in this field.

show abstract

Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder

et al. 2020

View full text Add to dashboard Cite

IMPORTANCE Evidence-based treatments from randomized clinical trials for pedophilic disorder are lacking.OBJECTIVE To determine whether a gonadotropin-releasing hormone antagonist reduces dynamic risk factors for committing child sexual abuse.DESIGN, SETTING, AND PARTICIPANTS This academically initiated, double-blind, placebo-controlled, parallel-group, phase 2 randomized clinical trial was conducted at the ANOVA center in Stockholm, Sweden, from March 1, 2016, to April 30, 2019. Individuals who contacted PrevenTell, the national telephone helpline for unwanted sexuality, were recruited. Eligible participants were men seeking help aged 18 to 66 years with a pedophilic disorder diagnosis and no contraindications to the intervention. The primary end point was assessed by intent-to-treat analysis.INTERVENTIONS Randomization to receive either 2 subcutaneous injections of 120 mg of degarelix acetate or equal volume of placebo. MAIN OUTCOMES AND MEASURESThe primary end point was the mean change between baseline and 2 weeks in the composite risk score of 5 domains of child sexual abuse ranging from 0 to 15 points; each domain could be rated from 0 to 3 points. Secondary end points included efficacy at 2 and 10 weeks as measured by the composite score, each risk domain, quality of life, self-reported effects, and adverse events. RESULTS A total of 52 male participants (mean [SD] age, 36 [12] years) were randomized to receive either degarelix (n = 25; with 1 withdrawal) or placebo (n = 26). At 2 weeks, the composite risk score decreased from 7.4 to 4.4 for participants in the degarelix group and from 7.8 to 6.6 for the placebo group, a mean between-group difference of -1.8 (95% CI, -3.2 to -0.5; P = .01). A decrease was seen in the composite score at 10 weeks (−2.2 [95% CI, −3.6 to −0.7]) as well as in the domains of pedophilic disorder (2 weeks: −0.7 [95% CI, −1.4 to 0.0]; 10 weeks: −1.1 [95% CI, −1.8 to −0.4]) and sexual preoccupation (2 weeks: −0.7 [95% CI, −1.2 to −0.3]; 10 weeks: −0.8 [95% CI, −1.3 to −0.3]) in the degarelix group compared with the placebo group. No difference was seen for the domains of self-rated risk (2 weeks: −0.4 [95% CI, −0.9 to 0.1]; 10 weeks: −0.5 [95% CI, −1 to 0.0]), low empathy (2 weeks: 0.2 [95% CI, −0.3 to 0.6]; 10 weeks: 0.2 [95% CI, −0.2 to 0.6]), and impaired self-regulation (2 weeks: −0.0 [95% CI, −0.7 to 0.6]; 10 weeks: 0.1 [95% CI, −0.5 to 0.8]), or quality of life (EuroQol 5 Dimensions questionnaire index score, 2 weeks: 0.06 [95% CI, −0.00 to 0.12], and 10 weeks: 0.04; 95% CI, −0.02 to 0.10; EuroQol visual analog scale, 2 weeks: 0.6 [95% CI, −9.7 to 10.9], and 10 weeks: 4.2 [95% CI, −6.0 to 14.4]). Two hospitalizations occurred from increased suicidal ideation, and more injection site reactions (degarelix: 22 of 25 [88%]; placebo: 1 of 26 [4%]) and hepatobiliary enzyme level elevations were reported by participants who received degarelix (degarelix: 11 of 25 [44%]; placebo: 2 of 26 [8%]). Among the 26 participants randomized to receive degarelix, 20 (77%) experienced positive eff...

show abstract

The sexual desire inventory: Development, factor structure, and evidence of reliability

Cited by 534 publications

References 17 publications

A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen

A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen

Sexual dysfunction in women with migraine versus tension-type headaches: a comparative study

Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder

Contact Info

Product

Resources

About